Understanding Mycotoxins: Survey and Sampling

Since 2004, the BIOMIN Mycotoxin Survey annual research analyzes thousands of agricultural commodity samples (corn, wheat, barley, rice, soy, silage and finished feed, etc.) from across the world as part of the PROcheck mycotoxin risk management warning system to identify the occurrence of mycotoxin-related risks to swine, poultry, beef and dairy cattle. Check out this video featuring Chasity Pender, poultry technical manager, to learn more about the mycotoxin survey and the importance of mycotoxin sampling. 

×

Trouble viewing this video? Watch it now on YouTube.

Published on

17 March 2025

Tags

  • Poultry
  • Mycotoxins

Related Articles

  • Mycotoxin Outlook for 2026 Harvest – Part 1

    Mycotoxin Outlook for 2026 Harvest – Part 1

    11 Sep 2026

    The 2026 corn growing season in North America yet again provided extreme weather events including record high temperatures and excessive rainfall in some places while others are experiencing severe drought conditions. Many factors influence the risk for mycotoxin contamination in crops, but climatic conditions play a critical role. While maximizing yield is often the goal, considerations for crop condition are also important heading into harvest. This article will provide an overview of major mycotoxigenic molds and key factors which influence the production of mycotoxins in corn. This will set the basis for next month’s article which will dig deeper into what contamination profiles might look like with the 2026 corn crop.

  • Mycotoxin biomarkers - is the hype justified?

    Mycotoxin biomarkers - is the hype justified?

    17 Aug 2026

    Despite the challenges which exist with mycotoxin analysis of feedstuffs, feed analysis continues to be the widely accepted way to monitor mycotoxin risk. An alternative approach which has garnered attention in recent years is the use of mycotoxin biomarkers – assessing mycotoxins via analysis of blood or other biological matrices (urine, bile, etc.) collected directly from animals. Although the use of biomarkers sounds like an exciting way to evaluate mycotoxin risk, there are also various limitations to consider. This article will provide insights into the use of mycotoxin biomarkers and highlight some of the current key challenges with this approach.

  • Fumonisins in swine: the hidden cost of subclinical exposure

    Fumonisins in swine: the hidden cost of subclinical exposure

    18 May 2026

    While high fumonisin levels are associated with clinical conditions such as porcine pulmonary edema, most commercial systems experience chronic, low to moderate exposure. Pigs often appear normal, yet underlying biological changes reduce efficiency, increase variability, and impact overall performance.